Kowa Pharma and Eli Lilly release PK study result

Singapore: Kowa Pharmaceuticals and Eli Lilly released results from a pharmacokinetic (PK) study exploring potential dru...

July 23, 2012 | Monday | News
TWi's diabetes drug recieves patent allowance from Europe, Russia

Singapore: Taiwan based TWi Biotechnology has received patent allowance for AC-201, its lead drug candidate, from the Eu...

August 3, 2015 | Monday | News
Japanese stem cell company ReproCELL acquires Biopta

Tokyo: Japanese regenerative medicine company ReproCELL Inc. has announced the acquisition of the Scottish life science...

November 26, 2015 | Thursday | News
IBM, A*Star co-develop anti-microbial hydrogel

Singapore: Researchers from A*Star's Institute of Bioengineering and Nanotechnology (IBN) and IBM have unveiled first-e...

January 24, 2013 | Thursday | News
Pfizer launches targeted therapy for lung cancer in Singapore

Singapore: Pfizer has launched Xalkori, a targeted therapy for ALK-positive non-small cell lung cancer (NSCLC), in Singa...

August 4, 2015 | Tuesday | Regulatory
HSA nod for Aslan rheumatoid arthritis drug

Singapore: Aslan Pharmaceuticals received approval by the Singapore Health Sciences Authority (HSA) for its Clinical Tri...

April 23, 2013 | Tuesday | Regulatory
Celsion launches cancer drug trial in China

Singapore: Celsion Corporation, a fully-integrated oncology company focused on the development of a portfolio of innovat...

March 8, 2016 | Tuesday | News
China SFDA passes Sihuan Pharma's Roxatidine

Singapore: Sihuan Pharmaceutical Holdings' roxatidine acetate hydrochloride for injection (Roxatidine), which is the com...

May 28, 2012 | Monday | News
Takeda, DND to accelerate drug discovery for parasite infection

Singapore: Geneva based Drugs for Neglected Diseases and Japan's Takeda have collaborated for a Lead Optimization Progra...

July 29, 2015 | Wednesday | News
Abbott marks success with naturally dissolving stent in Japan

Global life sciences company Abbott has announced that the company has observed positive clinical results from ABSORB Ja...

September 2, 2015 | Wednesday | News
BI shows afatinib to be effective in advanced squamous cell carcinoma of lung

Singapore: Boehringer Ingelheim has achieved positive results from the trial of afatinib in comparison to erlotinib in p...

June 11, 2015 | Thursday | News
Novartis partners with Mereo BioPharma to enhance novel drug portfolio

Singapore: Novartis has partnered with UK based Mereo BioPharma to develop compounds including BPS-804, to improve bone ...

July 31, 2015 | Friday | News
Jubilant Biosys collaborates with Sanofi to develop metabolic disorders therapy

Singapore: India based Jubilant Biosys, subsidiary of Jubilant Life Sciences, and Germany based Sanofi Deutschland have ...

January 11, 2016 | Monday | News
Amgen terninates phase III cancer trial

Singapore: Amgen decided to stop the ganitumab (AMG 479) phase III GAMMA (gemcitabine and AMG 479 in metastatic adenocar...

August 9, 2012 | Thursday | News
Minerva derives positive outcome of Insomnia drug study in Japanese patients

NASDAQ-listed Minerva Neurosciences Inc, a clinical-stage biopharmaceutical company focused on the development of therap...

February 2, 2016 | Tuesday | News
Singapore cancer genome scientists win President's Science Award

Singapore: A team comprising Professor Patrick Tan from Duke-NUS Graduate Medical School (Duke-NUS) and A*STAR's Genome ...

September 17, 2015 | Thursday | News
Positive results for Otsuka's MDR-TB treatment

Singapore: Clinical trial results on the safety and efficacy of delamanid, Otsuka Pharmaceutical's investigational compo...

June 7, 2012 | Thursday | News
Boehringer, Lilly complete type 2 diabetes study

Singapore: Recruitment of patients for CAROLINA (cardiovascular outcome study of Linagliptin versus Glimepiride in patie...

November 12, 2012 | Monday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls